ConditionSensitive Skin
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorShanghai Dermatology Hospital
About this trial
The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin
Eligibility criteria
Qualifiers
Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3
No related skin care products including bovine alkaline fibroblast growth factor were used within 1 month before participating in the experiment, and photoelectric treatment measures were not carried out
Physical sunscreen should be strict during enrollment
Disqualifiers
Children
Have serious heart, liver, kidney, and blood system diseases, and severe immunocompromise
Patients with mental illness or cancer
Those who have received glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics or tretinoin within 3 months
Trial design
Treatments tested in this trial
- bFGF
- Bovine Basic Gel
Treatment groups
28 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov